Skip to main content
Premium Trial:

Request an Annual Quote

Atlas Biolabs Named Roche NimbleGen CSP

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Roche NimgleGen today said that it has named Berlin, Germany-based Atlas Biolabs a certified service provider for the firm's SeqCap EZ enrichment product portfolio.

Atlas, which passed a certification process to qualify, will process customer gDNA samples for genomic enrichment using the complete NimbleGen Sequence Capture Array and solution-based capture workflow. The enriched samples can be analyzed afterward on the Roche GS FLX and GS Junior sequencing platforms, as well as on short-read sequencing platforms, said Roche.

Roche noted that its NimbleGen business recently launched a new addition to the SeqCap EZ product portfolio with SeqCap EZ Choice Libraries for enrichment of custom regions of interest in a single test tube.

Last September, Roche had announced that Aliso Viejo, Calif.-based Ambry Genetics was named a certified service provider for the Roche NimbleGen SeqCap EZ Exome workflow.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.